Last reviewed · How we verify
standardized turmeric root extract
standardized turmeric root extract is a Small molecule drug developed by Ramsey, Bonnie, MD. It is currently in Phase 1 development. Also known as: AFI Curcuminoids.
-
Baseline phase 1 → approval rate
+9.6pp
Industry-wide phase 1 drugs reach approval ~9.6% of the time (BIO/Informa 2023 industry benchmark across all therapeutic areas).
| Regulator | Country | Likely year | Lag vs FDA |
|---|---|---|---|
| FDA | US | 2033–2036 | — |
| EMA | EU | 2034–2037 | +0.7 yr |
| MHRA | GB | 2034–2037 | +0.7 yr |
| Health Canada | CA | 2034–2038 | +0.9 yr |
| TGA | AU | 2034–2038 | +1.2 yr |
| PMDA | JP | 2034–2038 | +1.5 yr |
| NMPA | CN | 2035–2039 | +2.3 yr |
| MFDS | KR | 2034–2038 | +1.4 yr |
| CDSCO | IN | 2034–2039 | +1.8 yr |
| ANVISA | BR | 2035–2039 | +2.3 yr |
Hover any row for the lag rationale. Lag estimates are reduced when the drug has FDA Breakthrough or EMA PRIME designation (sponsors file globally in parallel).
Estimate based on the BIO/Informa industry phase transition rates plus per-drug modifiers for therapeutic area, sponsor type, FDA designations, mechanism, and trial design. Per-jurisdiction lags from Tufts CSDD international approval studies. Not investment, clinical or regulatory advice. Methodology: /methodology#likelihood.
At a glance
| Generic name | standardized turmeric root extract |
|---|---|
| Also known as | AFI Curcuminoids |
| Sponsor | Ramsey, Bonnie, MD |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Curcumin, Resveratrol, and Stinging Nettle as Treatments for GWI (NA)
- Curcumin's Effect on Diabetic Patients With Atherosclerotic Cardiovascular Risk (PHASE2)
- Safety and Efficacy of Curcumin in Children With Acute Lymphoblastic Leukemia (PHASE2)
- Effect of Supplementation of Bioactive Compounds on the Energy Metabolism of People Living With HIV / AIDS (NA)
- Instaflex and Joint Pain in Community Adults (NA)
- Safety Study of Orally Administered Curcuminoids in Adult Subjects With Cystic Fibrosis (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- standardized turmeric root extract CI brief — competitive landscape report
- standardized turmeric root extract updates RSS · CI watch RSS
- Ramsey, Bonnie, MD portfolio CI
Frequently asked questions about standardized turmeric root extract
What is standardized turmeric root extract?
Who makes standardized turmeric root extract?
Is standardized turmeric root extract also known as anything else?
What development phase is standardized turmeric root extract in?
Related
- Manufacturer: Ramsey, Bonnie, MD — full pipeline
- Also known as: AFI Curcuminoids
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing